Amesite Inc Dossier
|
SectorInformation Technology IndustryApplication Software Beta (adjusted)1.02 Intrinsic Value No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference. Market Price $0.99Price as of 30 Sep 2026 Data confidence Sign in to view data confidence Market Cap $6.5M Enterprise Value $5.8M Shares Outstanding 6.5M diluted All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Amesite Inc. (NASDAQ: AMST) is undergoing a high-risk pivot from its legacy online educational technology platform to AI-driven healthcare software, primarily driven by its flagship NurseMagic™ clinical documentation app and modular EMR platform. While the company has demonstrated sequential revenue growth from a very small base and recently secured its largest enterprise deployment to date (a 2,700-patient census home care customer), its financial profile remains severely constrained. Amesite continues to generate substantial net losses, suffers from a high cash burn rate relative to its revenue, and has explicitly acknowledged substantial doubt regarding its ability to continue as a going concern. Although an April 2026 capital raise of approximately $2.6 million gross temporarily alleviated immediate liquidity and Nasdaq equity compliance pressures, the company relies heavily on dilutive equity financing and the potential exercise of outstanding warrants to fund operations. Given the lack of a proven path to profitability, intense competition from well-capitalized healthcare IT giants, and ongoing dilution risks, a cautious stance is warranted. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $0.5030% The bear case is driven by a failure to secure additional large-scale enterprise contracts, leading to stagnant revenue growth that cannot offset operating expenses. As cash reserves from the April 2026 offering deplete, the company's going concern risk intensifies, forcing further highly dilutive equity issuances or private placements at a deep discount. If the stock price falls or fails to maintain Nasdaq's minimum requirements, the company could face delisting, severely limiting liquidity and access to capital, ultimately threatening its operational viability. Base CaseCentral scenario $1.2050% In the base case, Amesite continues to grow its NurseMagic™ B2C and B2B revenue sequentially, but the absolute dollar amounts remain insufficient to cover its operating expenses over the next 12 months. The company remains unprofitable and continues to burn cash, requiring careful management of its remaining reserves. While the April 2026 capital raise keeps the company compliant with Nasdaq's stockholders' equity requirements in the near term, ongoing operational losses prevent significant share price appreciation, keeping the stock range-bound as the market monitors execution of the healthcare pivot. Bull CaseUpside scenario $2.5020% The bull case relies on rapid, high-margin enterprise adoption of the NurseMagic™ platform across the massive U.S. post-acute care market. If Amesite can leverage its recent 2,700-patient enterprise win to secure a robust pipeline of similar large-scale contracts, the high operating leverage of its SaaS model could drive exponential revenue growth. Furthermore, if stockholders approve the proposals at the July 2026 annual meeting, the full exercise of Series A-1 and Series A-2 warrants could inject up to $5.2 million in additional cash, resolving going concern doubts and funding product development without immediate further public offerings. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |